172 related articles for article (PubMed ID: 37151630)
1. Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients.
Zhu C; Wang X; Wang S; Hu J; Gao Y; Li C; Li J; Wu X
Heliyon; 2023 Apr; 9(4):e14594. PubMed ID: 37151630
[TBL] [Abstract][Full Text] [Related]
2. A novel clinical radiomics nomogram at baseline to predict mucosal healing in Crohn's disease patients treated with infliximab.
Zhu C; Hu J; Wang X; Li C; Gao Y; Li J; Ge Y; Wu X
Eur Radiol; 2022 Oct; 32(10):6628-6636. PubMed ID: 35857074
[TBL] [Abstract][Full Text] [Related]
3. A Novel Radiomics Nomogram for the Prediction of Secondary Loss of Response to Infliximab in Crohn's Disease.
Chen Y; Li H; Feng J; Suo S; Feng Q; Shen J
J Inflamm Res; 2021; 14():2731-2740. PubMed ID: 34194236
[TBL] [Abstract][Full Text] [Related]
4. Are Radiomic Spleen Features Useful for Assessing the Response to Infliximab in Patients With Crohn's Disease? A Multicenter Study.
Tang CT; Yin F; Yin Y; Liu Z; Long S; Zeng CY; Chen Y; Chen YX
Clin Transl Gastroenterol; 2024 May; 15(5):e00693. PubMed ID: 38407213
[TBL] [Abstract][Full Text] [Related]
5. A Novel Clinical Radiomics Nomogram to Identify Crohn's Disease from Intestinal Tuberculosis.
Zhu C; Yu Y; Wang S; Wang X; Gao Y; Li C; Li J; Ge Y; Wu X
J Inflamm Res; 2021; 14():6511-6521. PubMed ID: 34887674
[TBL] [Abstract][Full Text] [Related]
6. CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn's disease.
Yang T; Feng J; Yao R; Feng Q; Shen J
Insights Imaging; 2024 Mar; 15(1):69. PubMed ID: 38472447
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography enterography-based multiregional radiomics model for differential diagnosis of Crohn's disease from intestinal tuberculosis.
Gong T; Li M; Pu H; Yin LL; Peng SK; Zhou Z; Zhou M; Li H
Abdom Radiol (NY); 2023 Jun; 48(6):1900-1910. PubMed ID: 37004555
[TBL] [Abstract][Full Text] [Related]
8. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
9. Preoperative computed tomography enterography-based radiomics signature: A potential predictor of postoperative anastomotic recurrence in patients with Crohn's disease.
Shen XD; Zhang RN; Huang SY; Wang YD; Liu RY; Meng JX; Zhou J; Chen Z; Fang JY; Mao R; Li ZP; Sun CH; Feng ST; Lin SC; Zhong YK; Li XH
Eur J Radiol; 2023 May; 162():110766. PubMed ID: 36924538
[TBL] [Abstract][Full Text] [Related]
10. CTE-Based Radiomics Models Can Identify Mucosal Healing in Patients with Crohn's Disease.
Rong C; Zhu C; He L; Hu J; Gao Y; Li C; Qian B; Li J; Wu X
Acad Radiol; 2023 Sep; 30 Suppl 1():S199-S206. PubMed ID: 37210265
[TBL] [Abstract][Full Text] [Related]
11. CT-based radiomics signature of visceral adipose tissue and bowel lesions for identifying patients with Crohn's disease resistant to infliximab.
Wang Y; Luo Z; Zhou Z; Zhong Y; Zhang R; Shen X; Huang L; He W; Lin J; Fang J; Huang Q; Wang H; Zhang Z; Mao R; Feng ST; Li X; Huang B; Li Z; Zhang J; Chen Z
Insights Imaging; 2024 Jan; 15(1):28. PubMed ID: 38289416
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-based radiomics nomogram using machine learning for predicting 1-year surgical risk after diagnosis of Crohn's disease.
Yao J; Zhou J; Zhong Y; Zhang M; Peng X; Zhao J; Liu T; Wang W; Hu P; Meng X; Zhi M
Med Phys; 2023 Jun; 50(6):3862-3872. PubMed ID: 37029097
[TBL] [Abstract][Full Text] [Related]
13. CT enterography-based radiomics combined with body composition to predict infliximab treatment failure in Crohn's disease.
Song F; Ma M; Zeng S; Shao F; Huang W; Feng Z; Rong P
Radiol Med; 2024 Feb; 129(2):175-187. PubMed ID: 37982937
[TBL] [Abstract][Full Text] [Related]
14. A Novel Radiomics Model Integrating Luminal and Mesenteric Features to Predict Mucosal Activity and Surgery Risk in Crohn's Disease Patients: A Multicenter Study.
Ruiqing L; Jing Y; Shunli L; Jia K; Zhibo W; Hongping Z; Keyu R; Xiaoming Z; Zhiming W; Weiming Z; Tianye N; Yun L
Acad Radiol; 2023 Sep; 30 Suppl 1():S207-S219. PubMed ID: 37149448
[TBL] [Abstract][Full Text] [Related]
15. Intestinal fibrosis classification in patients with Crohn's disease using CT enterography-based deep learning: comparisons with radiomics and radiologists.
Meng J; Luo Z; Chen Z; Zhou J; Chen Z; Lu B; Zhang M; Wang Y; Yuan C; Shen X; Huang Q; Zhang Z; Ye Z; Cao Q; Zhou Z; Xu Y; Mao R; Chen M; Sun C; Li Z; Feng ST; Meng X; Huang B; Li X
Eur Radiol; 2022 Dec; 32(12):8692-8705. PubMed ID: 35616733
[TBL] [Abstract][Full Text] [Related]
16. Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia.
Li L; Wang L; Zeng F; Peng G; Ke Z; Liu H; Zha Y
Eur Radiol; 2021 Oct; 31(10):7901-7912. PubMed ID: 33786655
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.
Li X; Liang D; Meng J; Zhou J; Chen Z; Huang S; Lu B; Qiu Y; Baker ME; Ye Z; Cao Q; Wang M; Yuan C; Chen Z; Feng S; Zhang Y; Iacucci M; Ghosh S; Rieder F; Sun C; Chen M; Li Z; Mao R; Huang B; Feng ST
Gastroenterology; 2021 Jun; 160(7):2303-2316.e11. PubMed ID: 33609503
[TBL] [Abstract][Full Text] [Related]
18. Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study.
Ye XQ; Cai J; Yu Q; Cao XC; Chen Y; Rao MX; Chen BL; He Y; Zeng ZR; Chen H; Lin YM; Cao Q; Chen MH; Zhang SH
Gastroenterol Rep (Oxf); 2021 Aug; 9(4):329-338. PubMed ID: 34567565
[TBL] [Abstract][Full Text] [Related]
19. Infliximab response associates with radiologic findings in bio-naïve Crohn's disease.
Yueying C; Jing F; Qi F; Jun S
Eur Radiol; 2023 Aug; 33(8):5247-5257. PubMed ID: 36928565
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of CT-based radiomics nomogram for the classification of benign parotid gland tumors.
Zheng M; Chen Q; Ge Y; Yang L; Tian Y; Liu C; Wang P; Deng K
Med Phys; 2023 Feb; 50(2):947-957. PubMed ID: 36273307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
